The Current Status of Vaccine Uptake and the Impact of COVID-19 on Intention to Vaccination in Patients with COPD in Beijing

References

• World Health Organization. Evidence-informed policy network: EVIPnet in action. Available from: http://www.who.int/evidence. Accessed November 10, 2021.
   Google Scholar
• Soriano JB, Abajobir AA, Abate KH; GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5(9):691–706. doi:10.1016/S2213-2600(17)30293-X
   PubMed Web of Science ®Google Scholar
• Global strategy for the diagnosis, management and PRevention of Chronic Obstructive Pulmonary Disease, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2021 report. Available from: http://www.goldcopd.org/. Accessed January 15, 2021.
   Google Scholar
• Gershon AS, Chung H, Porter J, et al. Influenza vaccine effectiveness in preventing hospitalizations in older patients with chronic obstructive pulmonary disease. J Infect Dis. 2020;221(1):42–52. doi:10.1093/infdis/jiz419
   PubMed Web of Science ®Google Scholar
• Mohan A, Chandra S, Agarwal D, et al. Prevalence of viral infection detected by PCR and RT-PCR in patients with acute exacerbation of COPD: a systematic review. Respirology. 2010;15(3):536–542. doi:10.1111/j.1440-1843.2010.01722.x
   PubMed Web of Science ®Google Scholar
• Papi A, Bellettato CM, Braccioni F, et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med. 2006;173(10):1114–1121. doi:10.1164/rccm.200506-859OC
   PubMed Web of Science ®Google Scholar
• World Health Organization. Influenza (Seasonal). Available from: http://www.who.int/en/news-room/fact-sheets/detail/influenza-(seasonal). Accessed April 15, 2021.
   Google Scholar
• Mulpuru S, Li L, Ye L, et al. Effectiveness of influenza vaccination on hospitalizations and risk factors for severe outcomes in hospitalized patients with COPD. Chest. 2019;155(1):69–78. doi:10.1016/j.chest.2018.10.044
   PubMed Web of Science ®Google Scholar
• Bao W, Li Y, Wang T, et al. Effects of influenza vaccination on clinical outcomes of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Ageing Res Rev. 2021;68:101337. doi:10.1016/j.arr.2021.101337
   PubMed Web of Science ®Google Scholar
• Walters JA, Tang JN, Poole P, Wood-Baker R. Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2017;1(1):CD001390. doi:10.1002/14651858.CD001390.pub4
   PubMed Web of Science ®Google Scholar
• Fan J, Cong S, Wang N, et al. Influenza vaccination rate and its association with chronic diseases in China: results of a national cross-sectional study. Vaccine. 2020;38(11):2503–2511. doi:10.1016/j.vaccine.2020.01.093
   PubMed Web of Science ®Google Scholar
• Wang Y, Cheng M, Wang S, et al. Vaccination coverage with the pneumococcal and influenza vaccine among persons with chronic diseases in Shanghai, China, 2017. BMC Public Health. 2020;20(1):359. doi:10.1186/s12889-020-8388-3
   PubMed Web of Science ®Google Scholar
• Wang YH, Ye KY, Wang SY, et al. [Real world study of influenza vaccination intervention among key population of chronic disease management in Shanghai community]. Zhonghua Yu Fang Yi Xue Za Zhi. 2020;54(4):425–429. Chinese. doi:10.3760/cma.j.cn112150-20191031-00828
   PubMedGoogle Scholar
• Hsu DJ, North CM, Brode SK, Celli BR. Identification of barriers to influenza vaccination in patients with Chronic Obstructive Pulmonary Disease: analysis of the 2012 behavioral risk factors surveillance system. Chronic Obstr Pulm Dis. 2016;3(3):620–627. doi:10.15326/jcopdf.3.3.2015.0156
   PubMedGoogle Scholar
• Mowls DS, Cheruvu VK, Zullo MD. Influenza vaccination in adults with chronic obstructive pulmonary disease: the impact of a diagnostic breathing test on vaccination rates. PLoS One. 2013;8(6):e67600. doi:10.1371/journal.pone.0067600
   PubMed Web of Science ®Google Scholar
• Vozoris NT, Lougheed MD. Influenza vaccination among Canadians with chronic respiratory disease. Respir Med. 2009;103(1):50–58. doi:10.1016/j.rmed.2008.08.004
   PubMed Web of Science ®Google Scholar
• Garrastazu R, García-Rivero JL, Ruiz M, et al. Prevalence of influenza vaccination in Chronic Obstructive Pulmonary Disease patients and impact on the risk of severe exacerbations. Arch Bronconeumol. 2016;52(2):88–95. doi:10.1016/j.arbres.2015.09.001
   PubMed Web of Science ®Google Scholar
• Fan J, Cong S, Wang N, et al. [Pneumococcal vaccination rate in chronic obstructive pulmonary disease patients aged 40 years or older in China, 2014-2015]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(7):1028–1033. Chinese. doi:10.3760/cma.j.cn112338-20200124-00056
   PubMedGoogle Scholar
• Zhang M, Chen H, Wu F, et al. Heightened willingness toward pneumococcal vaccination in the elderly population in Shenzhen, China: a cross-sectional study during the COVID-19 pandemic. Vaccines. 2021;9(3):212. doi:10.3390/vaccines9030212
   PubMed Web of Science ®Google Scholar
• Huang HH, Chen SJ, Chao TF, et al. Influenza vaccination and risk of respiratory failure in patients with chronic obstructive pulmonary disease: a nationwide population-based case-cohort study. J Microbiol Immunol Infect. 2019;52(1):22–29. doi:10.1016/j.jmii.2017.08.014
   PubMedGoogle Scholar
• Joseph C, Elgohari S, Nichols T, Verlander N. Influenza vaccine uptake in adults aged 50-64 years: policy and practice in England 2003/2004. Vaccine. 2006;24(11):1786–1791. doi:10.1016/j.vaccine.2005.10.024
   PubMed Web of Science ®Google Scholar
• Hara M, Sakamoto T, Tanaka K. Influenza vaccine effectiveness among elderly persons living in the community during the 2003–2004 season. Vaccine. 2008;26(50):6477–6480. doi:10.1016/j.vaccine.2008.06.035
   PubMed Web of Science ®Google Scholar
• Kwong EW, Lam IO, Chan TM. What factors affect influenza vaccine uptake among community-dwelling older Chinese people in Hong Kong general outpatient clinics. J Clin Nurs. 2009;18(7):960–971. doi:10.1111/j.1365-2702.2008.02548.x
   PubMed Web of Science ®Google Scholar
• Alqahtani JS, Oyelade T, Aldhahir AM, et al. Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis. PLoS One. 2020;15(5):e0233147. doi:10.1371/journal.pone.0233147
   PubMed Web of Science ®Google Scholar
• Guan WJ, Liang WH, Zhao Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5):2000547. doi:10.1183/13993003.00547-2020
   PubMed Web of Science ®Google Scholar
• Wu Z, Hu Y, Xu M, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, Phase 1/2 clinical trial. Lancet Infect Dis. 2021;21(6):803–812. doi:10.1016/S1473-3099(20)30987-7
   PubMed Web of Science ®Google Scholar
• Logunov DY, Dolzhikova IV, Shcheblyakov DV, et al. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled Phase 3 trial in Russia. Lancet. 2021;397(10275):671–681. doi:10.1016/S0140-6736(21)00234-8
   PubMed Web of Science ®Google Scholar
• Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. 2021;384(5):403–416. doi:10.1056/NEJMoa2035389
   PubMed Web of Science ®Google Scholar
• Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–586. doi:10.1136/thx.54.7.581
   PubMed Web of Science ®Google Scholar
• Caminati M, Guarnieri G, Batani V, et al. COVID-19 vaccination in patients with severe asthma on biologic treatment: safety, tolerability, and impact on disease control. Vaccines. 2021;9(8):853. doi:10.3390/vaccines9080853
   Web of Science ®Google Scholar
• Chan WL, Ho YT, Wong CK, et al. Acceptance of COVID-19 vaccination in cancer patients in Hong Kong: approaches to improve the vaccination rate. Vaccines. 2021;9(7):792. doi:10.3390/vaccines9070792
   Web of Science ®Google Scholar
• Santos-Sancho JM, Jimenez-Trujillo I, Hernández-Barrera V, et al. Influenza vaccination coverage and uptake predictors among Spanish adults suffering COPD. Hum Vaccin Immunother. 2012;8(7):938–945. doi:10.4161/hv.20204
   PubMed Web of Science ®Google Scholar
• Yeung MP, Lam FL, Coker R. Factors associated with the uptake of seasonal influenza vaccination in adults: a systematic review. J Public Health. 2016;38(4):746–753. doi:10.1093/pubmed/fdv194
   Web of Science ®Google Scholar
• Li A, Chan YH, Liew MF, Pandey R, Phua J. Improving influenza vaccination coverage among patients with COPD: a pilot project. Int J Chron Obstruct Pulmon Dis. 2019;14:2527–2533. doi:10.2147/COPD.S222524
   PubMed Web of Science ®Google Scholar
• Bazargan M, Wisseh C, Adinkrah E, et al. Influenza vaccination among underserved African-American older adults. Biomed Res Int. 2020;2020:2160894. doi:10.1155/2020/2160894
   PubMed Web of Science ®Google Scholar
• Belingheri M, Roncalli M, Riva MA, Paladino ME, Teruzzi CM. COVID-19 vaccine hesitancy and reasons for or against adherence among dentists. J Am Dent Assoc. 2021;152(9):740–746. doi:10.1016/j.adaj.2021.04.020
   PubMed Web of Science ®Google Scholar
• Burke PF, Masters D, Massey G. Enablers and barriers to COVID-19 vaccine uptake: an international study of perceptions and intentions. Vaccine. 2021;39(36):5116–5128. doi:10.1016/j.vaccine.2021.07.056
   PubMed Web of Science ®Google Scholar
• Alibrahim J, Awad A. COVID-19 vaccine hesitancy among the public in Kuwait: a cross-sectional survey. Int J Environ Res Public Health. 2021;18(16):8836. doi:10.3390/ijerph18168836
   PubMed Web of Science ®Google Scholar
• Liu S, Xu E, Liu Y, et al. Factors associated with pneumococcal vaccination among an urban elderly population in China. Hum Vaccin Immunother. 2014;10(10):2994–2999. doi:10.4161/21645515.2014.972155
   PubMed Web of Science ®Google Scholar
• Zhang Y, Muscatello DJ, Wang Q, Yang P, Wu J, MacIntyre CR. Overview of influenza vaccination policy in Beijing, China: current status and future prospects. J Public Health Policy. 2017;38(3):366–379. doi:10.1057/s41271-017-0079-7
   PubMed Web of Science ®Google Scholar
• Wu S, Su J, Yang P, et al. Factors associated with the uptake of seasonal influenza vaccination in older and younger adults: a large, population-based survey in Beijing, China. BMJ Open. 2017;7(9):e017459. doi:10.1136/bmjopen-2017-017459
   PubMed Web of Science ®Google Scholar
• Lv M, Fang R, Wu J, et al. The free vaccination policy of influenza in Beijing, China: the vaccine coverage and its associated factors. Vaccine. 2016;34(18):2135–2140. doi:10.1016/j.vaccine.2016.02.032
   PubMed Web of Science ®Google Scholar
• Fekete M, Pako J, Nemeth AN, Tarantini S, Varga JT. Prevalence of influenza and pneumococcal vaccination in chronic obstructive pulmonary disease patients in association with the occurrence of acute exacerbations. J Thorac Dis. 2020;12(8):4233–4242. doi:10.21037/jtd-20-814
   PubMed Web of Science ®Google Scholar
• Ehteshami-Afshar S, Crothers K, Rodwin B, Bade B, Brandt C, Akgün KM. Does pulmonary subspecialty referral from primary care affect the adherence to vaccination recommendations in COPD patients. Respir Res. 2021;22(1):50. doi:10.1186/s12931-021-01639-6
   PubMed Web of Science ®Google Scholar